enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Dihydrotestosterone - Wikipedia

    en.wikipedia.org/wiki/Dihydrotestosterone

    In the case of women, mean circulating DHT levels have been found to be about 9 ng/dL (0.3 nmol/L) in premenopausal women and 3 ng/dL (0.1 nmol/L) in postmenopausal women. [5] There was no variation in DHT levels across the menstrual cycle in premenopausal women, which is in contrast to testosterone (which shows a peak at mid-cycle). [5]

  3. Clitoral enlargement methods - Wikipedia

    en.wikipedia.org/wiki/Clitoral_enlargement_methods

    Anecdotal evidence suggests that DHT (dihydrotestosterone), a very potent androgen, can effectively be used for this purpose with minimal side effects. No scientific studies have confirmed this effect in female anatomy, but research targeting the treatment of micropenis has found that local application of DHT is very effective at stimulating ...

  4. 5α-Reductase 2 deficiency - Wikipedia

    en.wikipedia.org/wiki/5α-Reductase_2_deficiency

    The development of female sex characteristics does not require DHT, so a lack of steroid 5-alpha reductase 2 activity does not cause physical changes in these individuals. [ 1 ] Virilization of genitalia with voice deepening, development of muscle mass occurs at puberty in affected individuals, and height is not impaired.

  5. Hirsutism - Wikipedia

    en.wikipedia.org/wiki/Hirsutism

    Hirsutism affects between 5 and 15% of women across all ethnic backgrounds. [8] Depending on the definition and the underlying data, approximately 40% of women have some degree of facial hair. [9] About 10 to 15% of cases of hirsutism are idiopathic with no known cause. [10]

  6. Complete androgen insensitivity syndrome - Wikipedia

    en.wikipedia.org/wiki/Complete_androgen...

    Complete androgen insensitivity syndrome (CAIS) is an AIS condition that results in the complete inability of the cell to respond to androgens. [1] [2] [3] As such, the insensitivity to androgens is only clinically significant when it occurs in individuals who are exposed to significant amounts of testosterone at some point in their lives. [1]

  7. Hair Loss in Women: Everything You Need to Know - AOL

    www.aol.com/hair-loss-women-everything-know...

    Risk Factors for Hair Loss in Women. There are quite a few risk factors for hair loss in women. They include: Age. FPHL usually develops around midlife and continues to progress as you get older.

  8. 5α-Reductase inhibitor - Wikipedia

    en.wikipedia.org/wiki/5α-reductase_inhibitor

    5α-Reductase inhibitors (5-ARIs), also known as dihydrotestosterone (DHT) blockers, are a class of medications with antiandrogenic effects which are used primarily in the treatment of enlarged prostate and scalp hair loss. They are also sometimes used to treat excess hair growth in women and as a component of hormone therapy for transgender ...

  9. Hyperandrogenism - Wikipedia

    en.wikipedia.org/wiki/Hyperandrogenism

    Hyperandrogenism is a medical condition characterized by high levels of androgens.It is more common in women than men. [4] Symptoms of hyperandrogenism may include acne, seborrhea, hair loss on the scalp, increased body or facial hair, and infrequent or absent menstruation.